Melanocytomas of the central nervous system: A clinicopathological and molecular study

European Journal of Clinical Investigation

Volumn 43, Issue 8, 2013, Pages 809-815

  Wang, Hai ^a   Zhang, Shu ^b   Wu, Chun ^a   Zhang, Zhiyuan ^a   Qin, Taichun ^c  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b NANTONG UNIVERSITY   (China)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

BRAF; Central Nervous System; Melanocytoma; Mutation; Prognosis; Radiotherapy

Indexed keywords

B RAF KINASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; DNA SEQUENCE; ELECTRON MICROSCOPY; EPITHELIOID CELL; FEMALE; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRACRANIAL TUMOR; MALE; MELANOCYTOSIS; MICROSCOPY; MITOSIS; NEVUS; ONCOGENE N RAS; PRIORITY JOURNAL; PROGNOSIS; SPINDLE CELL; TUMOR RECURRENCE;

EID: 84880735658     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12109     Document Type: Article

References (37)

1. Limas C, Tio FO. Meningeal melanocytoma ("melanotic meningioma"). Its melanocytic origin as revealed by electron microscopy. Cancer 1972;30:1286-94.
2. Gebarski SS, Blaivas MA. Imaging of normal leptomeningeal melanin. AJNR Am J Neuroradiol 1996;17:55-60.
3. Eskandari R, Schmidt MH. Intramedullary spinal melanocytoma. Rare tumors 2010;2:e24.
4. Prabhu SS, Lynch PG, Keogh AJ, Parekh HC. Intracranial meningeal melanocytoma: a report of two cases and a review of the literature. Surg Neurol 1993;40:516-21.
5. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. Mutations of the BRAF gene in human cancer. Nature 2002;417:949-54.
6. Russo AE, Torrisi E, Bevelacqua Y, Perrotta R, Libra M, McCubrey JA et al. Melanoma: molecular pathogenesis and emerging target therapies (Review). Int J Oncol 2009;34:1481-9.
7. Curtin JA, Busam K, Pinkel D, Bastian BC. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol 2006;24:4340-6.
8. Antonescu CR, Busam KJ, Francone TD, Wong GC, Guo T, Agaram NP et al. L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. Int J Cancer 2007;121:257-64.
9. Goel VK, Lazar AJ, Warneke CL, Redston MS, Haluska FG. Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma. J Invest Dermatol 2006;126:154-60.
10. Tang W, David FB, Wilson MM, Barwick BG, Leyland-Jones BR, Bouzyk MM. DNA extraction from formalin-fixed, paraffin-embedded tissue. Cold Spring Harb Protoc 2009; doi: 10.1101/pdb.prot5138.
11. Agbahiwe HC, Wharam M, Batra S, Cohen K, Terezakis SA. Management of Pediatric Myxopapillary Ependymoma: the role of adjuvant radiation. Int J Radiat Oncol Biol Phys 2013;85:421-7.
12. Classen J, Hehr T, Paulus W, Plate K, Bamberg M. Suprasellar melanocytoma: a case of primary radiotherapy and review of the literature. J Neurooncol 2002;58:39-46.
13. Ljumanovic R, Pouwels PJ, Langendijk JA, Knol DL, van der Valk P, Leemans CR et al. Has the degree of contrast enhancement with MR imaging in laryngeal carcinoma added value to anatomic parameters regarding prediction of response to radiation therapy? AJNR Am J Neuroradiol 2007;28:1540-6.
14. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109.
15. Rahimi-Movaghar V, Karimi M. Meningeal melanocytoma of the brain and oculodermal melanocytosis (nevus of Ota): case report and literature review. Surg Neurol 2003;59:200-10.
16. Piercecchi-Marti MD, Mohamed H, Liprandi A, Gambarelli D, Grisoli F, Pellissier JF. Intracranial meningeal melanocytoma associated with ipsilateral nevus of Ota. Case report. J Neurosurg 2002;96:619-23.
17. Navas M, Pascual JM, Fraga J, Pedrosa M, Shakur S, Carrasco R et al. Intracranial intermediate-grade meningeal melanocytoma with increased cellular proliferative index: an illustrative case associated with a nevus of Ota. J Neurooncol 2009;95:105-15.
18. Pan H, Wang H, Fan Y. Intracranial meningeal melanocytoma associated with nevus of Ota. J Clin Neurosci 2011;18:1548-50.
19. Hino K, Nagane M, Fujioka Y, Shiokawa Y. Meningeal melanocytoma associated with ipsilateral nevus of Ota presenting as intracerebral hemorrhage: case report. Neurosurgery 2005;56:E1376; discussion E.
20. Gupta A, Ahmad FU, Sharma MC, Garg A, Mehta VS. Cerebellopontine angle meningeal melanocytoma: a rare tumor in an uncommon location. Case report. J Neurosurg 2007;106:1094-7.
21. Litofsky NS, Zee CS, Breeze RE, Chandrasoma PT. Meningeal melanocytoma: diagnostic criteria for a rare lesion. Neurosurgery 1992;31:945-8.
22. O'Brien TF, Moran M, Miller JH, Hensley SD. Meningeal melanocytoma. An uncommon diagnostic pitfall in surgical neuropathology. Arch Pathol Lab Med 1995;119:542-6.
23. Uematsu Y, Yukawa S, Yokote H, Itakura T, Hayashi S, Komai N. Meningeal melanocytoma: magnetic resonance imaging characteristics and pathological features. Case report. J Neurosurg 1992;76:705-9.
24. Karikari IO, Powers CJ, Bagley CA, Cummings TJ, Radhakrishnan S, Friedman AH. Primary intramedullary melanocytoma of the spinal cord: case report. Neurosurgery 2009;64:E777-8; discussion E8.
25. Nakahara K, Morota N, Ihara S, Oka H, Matsuoka K, Nakagawa A. Meningeal melanocytoma extruded from the skull of a neonate-case report. Neurol Med Chir 2010;50:240-2.
26. Kumar R, Angelini S, Snellman E, Hemminki K. BRAF mutations are common somatic events in melanocytic nevi. J Invest Dermatol 2004;122:342-8.
27. Hocker T, Tsao H. Ultraviolet radiation and melanoma: a systematic review and analysis of reported sequence variants. Hum Mutat 2007;28:578-88.
28. Grossmann AH, Grossmann KF, Wallander ML. Molecular testing in malignant melanoma. Diagn Cytopathol 2012;40:503-10.
29. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM et al. High frequency of BRAF mutations in nevi. Nat Genet 2003;33:19-20.
30. Cohen Y, Rosenbaum E, Begum S, Goldenberg D, Esche C, Lavie O et al. Exon 15 BRAF mutations are uncommon in melanomas arising in nonsun-exposed sites. Clin Cancer Res 2004;10:3444-7.
31. Edwards RH, Ward MR, Wu H, Medina CA, Brose MS, Volpe P et al. Absence of BRAF mutations in UV-protected mucosal melanomas. J Med Genet 2004;41:270-2.
32. Wong CW, Fan YS, Chan TL, Chan AS, Ho LC, Ma TK et al. BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs. J Clin Pathol 2005;58:640-4.
33. Devitt B, Liu W, Salemi R, Wolfe R, Kelly J, Tzen CY et al. Clinical outcome and pathological features associated with NRAS mutation in cutaneous melanoma. Pigment Cell Melanoma Res 2011;24:666-72.
34. Ellerhorst JA, Greene VR, Ekmekcioglu S, Warneke CL, Johnson MM, Cooke CP et al. Clinical correlates of NRAS and BRAF mutations in primary human melanoma. Clin Cancer Res 2011;17:229-35.
35. Jiveskog S, Ragnarsson-Olding B, Platz A, Ringborg U. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. J Invest Dermatol 1998;111:757-61.
36. Wang F, Qiao G, Lou X, Song X, Chen W. Malignant transformation of intracranial meningeal melanocytoma. Case report and review of the literature. Neuropathology 2011;31:414-20.
37. Rades D, Schild SE, Tatagiba M, Molina HA, Alberti W. Therapy of meningeal melanocytomas. Cancer 2004;100:2442-7.